Acura Pharmaceuticals, INC
SEC CIK 786947 · ACUR.OB · last insider filing 2026-01-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Skelly William G | Director | filed 2006 - 2026 |
| Ross George K | Director | filed 2008 - 2026 |
| Thangaraj Immanuel | Director | filed 2007 - 2026 |
| Wesson Bruce F | Director | filed 2008 - 2024 |
| Jones Robert B | Director · Sr. VP & COO | filed 2008 - 2023 |
| Markham Richard J | Director | filed 2006 - 2013 |
| Azad David | Director | filed 2011 - 2012 |
| Reddick Andrew D | Director · President and CEO | filed 2008 - 2011 |
| Sumner William | Director | filed 2006 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Clemens Peter A | Senior VP and CFO | filed 2007 - 2023 |
| Seiser Robert A | VP, Treasurer & Controller | filed 2007 - 2023 |
| Brzeczko Albert W | VP, Pharmaceutical Sciences | filed 2009 - 2023 |
| Emigh James F | VP, Corporate Development | filed 2007 - 2021 |
| Rivet J Bradley | VP Marketing | filed 2011 - 2016 |
| Boehm Garth | VP Mod. Rel. Dosage Form Dev. | filed 2009 - 2009 |
| Spivey RON J | Sr VP/Chief Scientific Officer | filed 2008 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.